Back
Pyxis Oncology 10K Form
Sell
30
PYXS
Pyxis Oncology
Last Price:
4.42
Seasonality Move:
-13.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PYXS News And Ratings
See the #1 stock for the next 7 days that we like better than PYXS
PYXS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-15.25M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.81 |
| Price / Book: | 2.04 |
Profitability
| EPS (TTM): | -1.84000 |
|---|---|
| Net Income (TTM): | $-73.79M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Pyxis Oncology Earnings Forecast
Key Pyxis Oncology Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 2 years.
Pyxis Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PYXS |
| Website: | pyxisoncology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PYXS Technical Analysis vs Fundamental Analysis
Sell
30
Pyxis Oncology (PYXS)
is a Sell
Is Pyxis Oncology a Buy or a Sell?
-
Pyxis Oncology stock is rated a Sell
The current Pyxis Oncology [PYXS] share price is $4.41. The Score for PYXS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.